PT1891962E - Sistema de administração à base de glutationa - Google Patents
Sistema de administração à base de glutationa Download PDFInfo
- Publication number
- PT1891962E PT1891962E PT52928207T PT05292820T PT1891962E PT 1891962 E PT1891962 E PT 1891962E PT 52928207 T PT52928207 T PT 52928207T PT 05292820 T PT05292820 T PT 05292820T PT 1891962 E PT1891962 E PT 1891962E
- Authority
- PT
- Portugal
- Prior art keywords
- delivery system
- based delivery
- glutathione based
- glutathione
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyethers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/303,934 US7446096B2 (en) | 2005-12-19 | 2005-12-19 | Glutathione based delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1891962E true PT1891962E (pt) | 2014-11-11 |
Family
ID=36217526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT52928207T PT1891962E (pt) | 2005-12-19 | 2005-12-29 | Sistema de administração à base de glutationa |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US7446096B2 (pt) |
| EP (2) | EP1891962B1 (pt) |
| JP (2) | JP4773200B2 (pt) |
| CN (2) | CN1985804B (pt) |
| CY (1) | CY1115542T1 (pt) |
| DK (1) | DK1891962T3 (pt) |
| ES (1) | ES2516665T3 (pt) |
| PL (1) | PL1891962T3 (pt) |
| PT (1) | PT1891962E (pt) |
| SI (1) | SI1891962T1 (pt) |
| TW (1) | TWI365754B (pt) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| US20040057983A1 (en) | 2002-09-25 | 2004-03-25 | David Schmidt | Biomolecular wearable apparatus |
| CA2557354C (en) * | 2004-03-03 | 2013-05-07 | Vital Health Sciences Pty Ltd. | Alkaloid formulations |
| CA2575587C (en) * | 2004-08-03 | 2014-06-17 | Vital Health Sciences Pty Ltd | Carrier for enteral administration |
| US20090239827A1 (en) * | 2005-03-03 | 2009-09-24 | Esra Ogru | Compounds having lipid lowering properties |
| US9168216B2 (en) | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| US8067380B2 (en) * | 2005-12-19 | 2011-11-29 | Industrial Technology Research Institute | Glutathione-based delivery system |
| US7446096B2 (en) * | 2005-12-19 | 2008-11-04 | Industrial Technology Research Institute | Glutathione based delivery system |
| EP2125024B1 (en) * | 2007-03-23 | 2013-02-13 | TO-BBB Holding B.V. | Targeted intracellular delivery of antiviral agents |
| FR2926725B1 (fr) * | 2008-01-25 | 2010-09-03 | Biochimie Appliquee Soc | Compositions cosmetiques et/ou dermatologiques cicatrisantes |
| US8602961B2 (en) | 2008-05-15 | 2013-12-10 | Lifewave Products Llc | Apparatus and method of stimulating elevation of glutathione levels in a subject |
| WO2010061881A1 (ja) | 2008-11-26 | 2010-06-03 | 中外製薬株式会社 | Ｃ型肝炎ウイルスの働きを阻害するオリゴリボヌクレオチドまたはペプチド核酸 |
| KR101727333B1 (ko) * | 2008-11-26 | 2017-04-14 | 추가이 세이야쿠 가부시키가이샤 | 베시클 제제 |
| DK2398500T3 (da) * | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
| AU2011213557B2 (en) | 2010-02-05 | 2015-05-07 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| BR112012024835A2 (pt) * | 2010-03-30 | 2016-06-07 | Phosphagenics Ltd | adesivo de distribuição transdérmica |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| GB201302427D0 (en) | 2013-02-12 | 2013-03-27 | Midatech Ltd | Nanoparticle delivery compositions |
| EP3038657A2 (en) | 2013-08-28 | 2016-07-06 | Bioasis Technologies Inc. | Cns-targeted conjugates having modified fc regions and methods of use thereof |
| JP6529012B2 (ja) | 2013-10-08 | 2019-06-12 | エイアイ・セラピューティクス・インコーポレーテッド | リンパ脈管筋腫症の処置のためのラパマイシン |
| US10765755B1 (en) * | 2013-11-20 | 2020-09-08 | University Of South Florida | Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies |
| CA2944075C (en) | 2014-04-04 | 2022-06-28 | Lam Therapeutics, Inc. | An inhalable rapamycin formulation for treating age-related conditions |
| WO2015154897A1 (en) * | 2014-04-08 | 2015-10-15 | Wolfgang Stremmel | Means and methods for treating disorders of copper metabolism |
| WO2015161295A1 (en) * | 2014-04-17 | 2015-10-22 | The Corporation Of Mercer University | Vitamin e-based nanocarriers for drug delivery and methods of making and using the same |
| RU2732908C2 (ru) | 2014-10-07 | 2020-09-24 | ЭйАй ТЕРАПЬЮТИКС, ИНК. | Ингаляционная лекарственная форма рапамицина для лечения легочной гипертензии |
| US10758520B1 (en) | 2015-05-20 | 2020-09-01 | University Of South Florida | Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain barrier |
| EP3383371B1 (en) | 2015-12-09 | 2024-05-01 | Avecho Biotechnology Limited | Pharmaceutical formulation |
| CA3045702A1 (en) | 2016-12-21 | 2018-06-28 | Phosphagenics Limited | Phosphorylation process of complex alcohols |
| US10226442B2 (en) * | 2017-07-10 | 2019-03-12 | Syneurx International (Taiwan) Corp. | Lithium salts of N-substituted glycine compounds and uses thereof |
| US10842755B2 (en) | 2018-03-23 | 2020-11-24 | University Of South Carolina | Nanoparticles for brain targeted drug delivery |
| US20200048305A1 (en) * | 2018-08-10 | 2020-02-13 | South Dakota Board Of Regents | Glutathione-cholesterol derivatives as brain targeting agents |
| KR102465308B1 (ko) * | 2019-05-28 | 2022-11-11 | 울산과학기술원 | 글루타치온-ｓ-전이효소 및 표적 세포 또는 표적 단백질 결합능을 갖는 단백질을 포함하는 리포좀 및 이의 용도 |
| CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
| TW202228792A (zh) | 2020-10-09 | 2022-08-01 | 殷漢生技股份有限公司 | 吸入用奈米載體製劑 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60142915A (ja) | 1983-12-28 | 1985-07-29 | Lion Corp | 口腔用組成物 |
| JPS632922A (ja) | 1986-06-20 | 1988-01-07 | Yamanouchi Pharmaceut Co Ltd | ドラツグキヤリア |
| JPH0714865B2 (ja) * | 1986-10-28 | 1995-02-22 | 武田薬品工業株式会社 | リポソ−ム製剤およびその製造法 |
| FR2627385B3 (fr) | 1988-02-23 | 1991-08-23 | Serobiologiques Lab Sa | Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques |
| US5695751A (en) | 1993-04-08 | 1997-12-09 | Cornell Research Foundation, Inc. | Enhancing delivery of large neutral amino acid drugs |
| JPH0834779A (ja) * | 1994-05-20 | 1996-02-06 | Senju Pharmaceut Co Ltd | トコフェロール誘導体 |
| US6653331B2 (en) | 1996-07-03 | 2003-11-25 | Pharmacia & Upjohn Company | Targeted drug delivery using sulfonamide derivatives |
| WO1998008490A1 (en) * | 1996-09-01 | 1998-03-05 | Pharmos Corporation | Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| JP2001503396A (ja) * | 1996-10-11 | 2001-03-13 | アルザ コーポレイション | 治療用リポソーム組成物および方法 |
| US6228347B1 (en) | 1997-12-01 | 2001-05-08 | Thione International, Inc. | Antioxidant gel for gingival conditions |
| CA2328731A1 (en) * | 1998-04-16 | 1999-10-28 | Atsushi Imaizumi | Glutathione derivatives and dosage forms thereof |
| JP2004323486A (ja) * | 2003-04-30 | 2004-11-18 | National Institute Of Advanced Industrial & Technology | 網膜及び／又はブドウ膜疾患の予防乃至治療用点眼薬 |
| CN100515390C (zh) * | 2005-04-14 | 2009-07-22 | 蔡海德 | 垂体前叶肾上腺皮质提取物纳米脂质体组合药物及其制备方法和用途 |
| US7446096B2 (en) * | 2005-12-19 | 2008-11-04 | Industrial Technology Research Institute | Glutathione based delivery system |
| US8067380B2 (en) * | 2005-12-19 | 2011-11-29 | Industrial Technology Research Institute | Glutathione-based delivery system |
-
2005
- 2005-12-19 US US11/303,934 patent/US7446096B2/en active Active
- 2005-12-27 JP JP2005374896A patent/JP4773200B2/ja active Active
- 2005-12-29 DK DK05292820.7T patent/DK1891962T3/da active
- 2005-12-29 PT PT52928207T patent/PT1891962E/pt unknown
- 2005-12-29 PL PL05292820T patent/PL1891962T3/pl unknown
- 2005-12-29 ES ES05292820.7T patent/ES2516665T3/es active Active
- 2005-12-29 EP EP05292820.7A patent/EP1891962B1/en active Active
- 2005-12-29 SI SI200531880T patent/SI1891962T1/sl unknown
- 2005-12-29 EP EP14180310.6A patent/EP2837384A1/en not_active Ceased
- 2005-12-30 TW TW094147661A patent/TWI365754B/zh active
-
2006
- 2006-01-19 CN CN200610005869.0A patent/CN1985804B/zh active Active
- 2006-01-19 CN CN2008101693581A patent/CN101385859B/zh active Active
-
2007
- 2007-12-11 US US12/000,261 patent/US7704956B2/en not_active Expired - Fee Related
-
2008
- 2008-11-03 US US12/263,885 patent/US7700564B2/en active Active
-
2010
- 2010-01-15 JP JP2010007125A patent/JP5394944B2/ja active Active
- 2010-03-11 US US12/721,633 patent/US8569239B2/en active Active
-
2014
- 2014-09-10 CY CY20141100728T patent/CY1115542T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL1891962T3 (pl) | 2015-01-30 |
| US20070141133A1 (en) | 2007-06-21 |
| CN1985804A (zh) | 2007-06-27 |
| US20100166849A1 (en) | 2010-07-01 |
| US20090060991A1 (en) | 2009-03-05 |
| EP1891962B1 (en) | 2014-08-13 |
| SI1891962T1 (sl) | 2014-12-31 |
| JP2007169252A (ja) | 2007-07-05 |
| EP1891962A1 (en) | 2008-02-27 |
| JP5394944B2 (ja) | 2014-01-22 |
| CN1985804B (zh) | 2014-05-14 |
| EP2837384A1 (en) | 2015-02-18 |
| US7704956B2 (en) | 2010-04-27 |
| US7446096B2 (en) | 2008-11-04 |
| US20080095836A1 (en) | 2008-04-24 |
| CY1115542T1 (el) | 2017-01-04 |
| ES2516665T3 (es) | 2014-10-31 |
| US8569239B2 (en) | 2013-10-29 |
| JP4773200B2 (ja) | 2011-09-14 |
| CN101385859B (zh) | 2011-12-07 |
| JP2010150264A (ja) | 2010-07-08 |
| DK1891962T3 (da) | 2014-10-13 |
| CN101385859A (zh) | 2009-03-18 |
| TWI365754B (en) | 2012-06-11 |
| US7700564B2 (en) | 2010-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI365754B (en) | Glutathione based delivery system | |
| IL278979A (en) | Pharma-Informatics system | |
| EP1865925A4 (en) | ORAL ADMINISTRATION METHOD | |
| IL184824A0 (en) | Infusion delivery system | |
| EP2061261A4 (en) | STEREO PROJECTION SYSTEM | |
| GB0517035D0 (en) | Delivery system | |
| EP1902360A4 (en) | SYSTEM FOR RELEASING CONTENT | |
| GB2432827B (en) | Fragrance delivery system | |
| ZA200804176B (en) | A delivery system | |
| EP1891801A4 (en) | DOCUMENT DISTRIBUTION SYSTEM | |
| GB2431563B (en) | Watersport hiking-support system | |
| GB0511518D0 (en) | Nofog system | |
| GB2433249B (en) | Pumping system | |
| GB0504771D0 (en) | System | |
| EP1857537A4 (en) | PUMPING SYSTEM FOR FLUIDS | |
| GB0518674D0 (en) | System | |
| GB2427760B (en) | Antenna-transceiver system | |
| GB0525355D0 (en) | Delivery system | |
| GB0519069D0 (en) | Delivery system | |
| ZA200610015B (en) | Nutrient delivery system | |
| GB2430017B (en) | Connection system | |
| AU2005902906A0 (en) | Delivery system | |
| AU2005905750A0 (en) | Delivery system | |
| PL114959U1 (en) | Delivery system | |
| GB0513683D0 (en) | Advanced parcel delivery system |